Performance enhancing drug abuse and cardiovascular risk in athletes: implications for the clinician.

Performance enhancing drug abuse and cardiovascular risk in athletes: implications for the clinician.

Item
http://www.wikidata.org/entity/Q34308135
Synthetic androgens as designer supplementsAdverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.Alternative drugs of abuse.Doping in sport and exercise: anabolic, ergogenic, health and clinical issues.Sudden cardiac arrest in sports - need for uniform registration: A Position Paper from the Sport Cardiology Section of the European Association for Cardiovascular Prevention and Rehabilitation.Direct analysis in real time - high resolution mass spectrometry (DART-HRMS): a high throughput strategy for identification and quantification of anabolic steroid esters.Metabolism of Oral Turinabol by Human Steroid Hormone-Synthesizing Cytochrome P450 Enzymes.The multi-modality cardiac imaging approach to the Athlete's heart: an expert consensus of the European Association of Cardiovascular Imaging.Prolonged androgenic anabolic steroid (AAS) induced QT interval shortening: a suitable screening tool?
P2860

Performance enhancing drug abuse and cardiovascular risk in athletes: implications for the clinician.

Item
http://www.wikidata.org/entity/Q34308135
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Performance enhancing drug abu ...... mplications for the clinician.
@ast
Performance enhancing drug abu ...... mplications for the clinician.
@en
Performance enhancing drug abu ...... mplications for the clinician.
@nl
type
label
Performance enhancing drug abu ...... mplications for the clinician.
@ast
Performance enhancing drug abu ...... mplications for the clinician.
@en
Performance enhancing drug abu ...... mplications for the clinician.
@nl
prefLabel
Performance enhancing drug abu ...... mplications for the clinician.
@ast
Performance enhancing drug abu ...... mplications for the clinician.
@en
Performance enhancing drug abu ...... mplications for the clinician.
@nl
P1433
P1476
P2093
P304
P31
P356
P478
P50
P577
P5875
P698
P356
P1433
P1476
Performance enhancing drug abu ...... implications for the clinician
@en
P2093
P304
P31
P356
10.1136/BJSPORTS-2012-091186
P478
P50
P577
P5875
P698